Download IMRIS Inc. - Barchart.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2014
Commission File Number: 001-34975
IMRIS INC.
(Translation of registrant's name into English)
100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 Form 20-F
 Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): 
INCORPORATION BY REFERENCE
Exhibits 99.1 to this Form 6-K shall be incorporated by reference as an exhibit to the Registration Statement of IMRIS Inc. on Form F-10 (File
No. 333-183820).
DOCUMENTS FILED AS PART OF THIS FORM 6-K
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
IMRIS Inc.
(Registrant)
Date: April 24, 2014
By:
/s/ Kelly McNeill
_____________________________________
Name:
Kelly McNeill
Title:
Executive Vice President Finance and Administration &
CFO
EXHIBIT INDEX
99.1
News Release Dated April 24, 2014 - Tampa General Hospital launches advanced intraoperative MRI use with first cases
Exhibit 99.1
Tampa General Hospital launches advanced intraoperative MRI use with first cases
IMRIS VISIUS iMRI improves surgical results and patient outcomes for neurosurgery
MINNEAPOLIS, April 24, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a
University of South Florida neurosurgical team at Tampa General Hospital (TGH) completed initial cases last week using its recently installed
VISIUS intraoperative MRI - providing the most advanced surgery and operating suite in the Tampa Bay area. The first case was a right
parietal high-grade glioma - a type of brain tumor.
(Photo: http://photos.prnewswire.com/prnh/20140423/77700)
"We can now see how a patient's surgery is going and affect the outcome rather than complete the surgery and accept the outcome," said Dr.
Harry van Loveren, TGH neurosurgeon, interim dean of the University of South Florida Morsani College of Medicine, and chair of the
college's department of neurosurgery and brain repair. "Having this level of imaging available during complicated neurosurgeries, we anticipate
improving surgical results and reducing the number of re-operations."
The two-room VISIUS Surgical Theatre at TGH features a high-field MR that travels to the patient using ceiling-mounted rails. The fully
integrated suite allows the scanner to move between an operating room and a diagnostic room, providing on-demand access to high resolution
MR images - before, during and after procedures without moving the patient from the OR table.
"This provides the most advanced imaging for Tampa area surgeons during operations," said Jay D. Miller, IMRIS President and CEO.
"Hospitals are recognizing the advantage of enhanced visualization in the operating room and reduced risks by not moving patients during
surgery and avoiding re-operation. Many of the top neuroscience centers are making this solution their standard of care."
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making
and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed
effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular
markets and have been selected by 57 leading medical institutions around the world.
SOURCE IMRIS Inc.
%CIK: 0001489161
For further information:
Kevin J. Berger
Marketing Communications Manager
IMRIS Inc.
Tel: 763-203-6332
Email: [email protected]
CO: IMRIS Inc.
CNW 08:00e 24-APR-14